Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Nov;88(5):1613–1621. doi: 10.1172/JCI115474

Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.

S W Blume 1, R C Snyder 1, R Ray 1, S Thomas 1, C A Koller 1, D M Miller 1
PMCID: PMC295684  PMID: 1834700

Abstract

The promoter of the human dihydrofolate reductase (DHFR) gene contains two consensus binding sites for the DNA binding protein Sp1. DNAse protection and gel mobility shift assays demonstrate binding of recombinant Sp1 to both decanucleotide Sp1 binding sequences which are located 49 and 14 base pairs upstream of the transcription start site. The more distal of the two binding sites exhibits a somewhat higher affinity for Sp1. The G-C specific DNA binding drug, mithramycin, binds to both consensus sequences and prevents subsequent Sp1 binding. Promoter-dependent in vitro transcription of a DHFR template is selectively inhibited by mithramycin when compared to the human H2b histone gene. A similar effect is also noted in vivo. Mithramycin treatment of MCF-7 human breast carcinoma cells containing an amplified DHFR gene induces selective inhibition of DHFR transcription initiation, resulting in a decline in DHFR mRNA level and enzyme activity. This selective inhibition of DHFR expression suggests that it is possible to modulate the overexpression of the DHFR gene in methotrexate resistant cells.

Full text

PDF
1613

Images in this article

1615Image
on p.1615
1616Image
on p.1616
1616Image
on p.1616
1617Image
on p.1617
1617Image
on p.1617
1617Image
on p.1617
1618Image
on p.1618
1618Image
on p.1618
1618Image
on p.1618

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alt F. W., Kellems R. E., Bertino J. R., Schimke R. T. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem. 1978 Mar 10;253(5):1357–1370. [PubMed] [Google Scholar]
  2. Ayusawa D., Shimizu K., Koyama H., Takeishi K., Seno T. Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3A cells. J Biol Chem. 1983 Oct 25;258(20):12448–12454. [PubMed] [Google Scholar]
  3. Azizkhan J. C., Vaughn J. P., Christy R. J., Hamlin J. L. Nucleotide sequence and nuclease hypersensitivity of the Chinese hamster dihydrofolate reductase gene promoter region. Biochemistry. 1986 Oct 7;25(20):6228–6236. doi: 10.1021/bi00368a059. [DOI] [PubMed] [Google Scholar]
  4. Berlin Y. U., Kiseleva O. A., Kolosov M. N., Shemyakin M. M., Soifer V. S. Aureolic acid group of anti-tumour antibiotics. Nature. 1968 Apr 13;218(5137):193–194. doi: 10.1038/218193a0. [DOI] [PubMed] [Google Scholar]
  5. Bleyer W. A. Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev. 1977 Jun;4(2):87–101. doi: 10.1016/s0305-7372(77)80007-8. [DOI] [PubMed] [Google Scholar]
  6. Bostock C. J., Clark E. M., Harding N. G., Mounts P. M., Tyler-Smith C., van Heyningen V., Walker P. M. The development of resistance to methotrexate in a mouse melanoma cell line. I. Characterisation of the dihydrofolate reductases and chromosomes in sensitive and resistant cells. Chromosoma. 1979;74(2):153–177. doi: 10.1007/BF00292270. [DOI] [PubMed] [Google Scholar]
  7. Bouchard J., Bastow K. F., Starnes M. C., Prabhu R., Cheng Y. C. Characterization of dihydrofolate reductase-related DNA and RNA from human KB cell subclones containing different amounts of enzyme. Cancer Res. 1985 Apr;45(4):1717–1722. [PubMed] [Google Scholar]
  8. Carman M. D., Schornagel J. H., Rivest R. S., Srimatkandada S., Portlock C. S., Duffy T., Bertino J. R. Resistance to methotrexate due to gene amplification in a patient with acute leukemia. J Clin Oncol. 1984 Jan;2(1):16–20. doi: 10.1200/JCO.1984.2.1.16. [DOI] [PubMed] [Google Scholar]
  9. Chen M. J., Shimada T., Moulton A. D., Cline A., Humphries R. K., Maizel J., Nienhuis A. W. The functional human dihydrofolate reductase gene. J Biol Chem. 1984 Mar 25;259(6):3933–3943. [PubMed] [Google Scholar]
  10. Corin R. E., Turner T., Szabo P. Murine erythroleukemia cell variants: isolation of cells that have amplified the dihydrofolate reductase gene and retained the ability to be induced to differentiate. Biochemistry. 1986 Jul 1;25(13):3768–3773. doi: 10.1021/bi00361a006. [DOI] [PubMed] [Google Scholar]
  11. Cowan K. H., Goldsmith M. E., Levine R. M., Aitken S. C., Douglass E., Clendeninn N., Nienhuis A. W., Lippman M. E. Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. J Biol Chem. 1982 Dec 25;257(24):15079–15086. [PubMed] [Google Scholar]
  12. Cowan K. H., Goldsmith M. E., Ricciardone M. D., Levine R., Rubalcaba E., Jolivet J. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene. Mol Pharmacol. 1986 Jul;30(1):69–76. [PubMed] [Google Scholar]
  13. Curt G. A., Carney D. N., Cowan K. H., Jolivet J., Bailey B. D., Drake J. C., Chien Song K. S., Minna J. D., Chabner B. A. Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. N Engl J Med. 1983 Jan 27;308(4):199–202. doi: 10.1056/NEJM198301273080406. [DOI] [PubMed] [Google Scholar]
  14. Dawson P. A., Hofmann S. L., van der Westhuyzen D. R., Südhof T. C., Brown M. S., Goldstein J. L. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J Biol Chem. 1988 Mar 5;263(7):3372–3379. [PubMed] [Google Scholar]
  15. Dynan W. S., Sazer S., Tjian R., Schimke R. T. Transcription factor Sp1 recognizes a DNA sequence in the mouse dihydrofolate reductase promoter. Nature. 1986 Jan 16;319(6050):246–248. doi: 10.1038/319246a0. [DOI] [PubMed] [Google Scholar]
  16. Dynan W. S., Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 1983 Nov;35(1):79–87. doi: 10.1016/0092-8674(83)90210-6. [DOI] [PubMed] [Google Scholar]
  17. Farnham P. J., Schimke R. T. In vitro transcription and delimitation of promoter elements of the murine dihydrofolate reductase gene. Mol Cell Biol. 1986 Jul;6(7):2392–2401. doi: 10.1128/mcb.6.7.2392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Farnham P. J., Schimke R. T. Transcriptional regulation of mouse dihydrofolate reductase in the cell cycle. J Biol Chem. 1985 Jun 25;260(12):7675–7680. [PubMed] [Google Scholar]
  19. Frei E., 3rd, Rosowsky A., Wright J. E., Cucchi C. A., Lippke J. A., Ervin T. J., Jolivet J., Haseltine W. A. Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. Proc Natl Acad Sci U S A. 1984 May;81(9):2873–2877. doi: 10.1073/pnas.81.9.2873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gidoni D., Dynan W. S., Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. 1984 Nov 29-Dec 5Nature. 312(5993):409–413. doi: 10.1038/312409a0. [DOI] [PubMed] [Google Scholar]
  21. Goldsmith M. E., Beckman C. A., Cowan K. H. 5' Nucleotide sequences influence serum-modulated expression of a human dihydrofolate reductase minigene. Mol Cell Biol. 1986 Mar;6(3):878–886. doi: 10.1128/mcb.6.3.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gupta R. S. Species specific differences in the toxicity of mithramycin, chromomycin A3, and olivomycin towards cultured mammalian cells. J Cell Physiol. 1982 Oct;113(1):11–16. doi: 10.1002/jcp.1041130104. [DOI] [PubMed] [Google Scholar]
  23. Hendrickson S. L., Wu J. S., Johnson L. F. Cell cycle regulation of dihydrofolate reductase mRNA metabolism in mouse fibroblasts. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5140–5144. doi: 10.1073/pnas.77.9.5140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Horns R. C., Jr, Dower W. J., Schimke R. T. Gene amplification in a leukemic patient treated with methotrexate. J Clin Oncol. 1984 Jan;2(1):2–7. doi: 10.1200/JCO.1984.2.1.2. [DOI] [PubMed] [Google Scholar]
  25. Ishii S., Kadonaga J. T., Tjian R., Brady J. N., Merlino G. T., Pastan I. Binding of the Sp1 transcription factor by the human Harvey ras1 proto-oncogene promoter. Science. 1986 Jun 13;232(4756):1410–1413. doi: 10.1126/science.3012774. [DOI] [PubMed] [Google Scholar]
  26. Jones K. A., Kadonaga J. T., Luciw P. A., Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science. 1986 May 9;232(4751):755–759. doi: 10.1126/science.3008338. [DOI] [PubMed] [Google Scholar]
  27. Jones K. A., Yamamoto K. R., Tjian R. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell. 1985 Sep;42(2):559–572. doi: 10.1016/0092-8674(85)90113-8. [DOI] [PubMed] [Google Scholar]
  28. Kadonaga J. T., Carner K. R., Masiarz F. R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987 Dec 24;51(6):1079–1090. doi: 10.1016/0092-8674(87)90594-0. [DOI] [PubMed] [Google Scholar]
  29. Kadonaga J. T., Courey A. J., Ladika J., Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science. 1988 Dec 16;242(4885):1566–1570. doi: 10.1126/science.3059495. [DOI] [PubMed] [Google Scholar]
  30. Kleinberger T., Etkin S., Lavi S. Carcinogen-mediated methotrexate resistance and dihydrofolate reductase amplification in Chinese hamster cells. Mol Cell Biol. 1986 Jun;6(6):1958–1964. doi: 10.1128/mcb.6.6.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Koller C. A., Campbell V. W., Polansky D. A., Mulhern A., Miller D. M. In vivo differentiation of blast-phase chronic granulocytic leukemia. Expression of c-myc and c-abl protooncogenes. J Clin Invest. 1985 Jul;76(1):365–369. doi: 10.1172/JCI111970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Koller C. A., Miller D. M. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med. 1986 Dec 4;315(23):1433–1438. doi: 10.1056/NEJM198612043152301. [DOI] [PubMed] [Google Scholar]
  33. Lee W., Haslinger A., Karin M., Tjian R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature. 1987 Jan 22;325(6102):368–372. doi: 10.1038/325368a0. [DOI] [PubMed] [Google Scholar]
  34. Levine R. M., Rubalcaba E., Lippman M. E., Cowan K. H. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line. Cancer Res. 1985 Apr;45(4):1644–1650. [PubMed] [Google Scholar]
  35. Looney J. E., Hamlin J. L. Isolation of the amplified dihydrofolate reductase domain from methotrexate-resistant Chinese hamster ovary cells. Mol Cell Biol. 1987 Feb;7(2):569–577. doi: 10.1128/mcb.7.2.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lorico A., Toffoli G., Boiocchi M., Erba E., Broggini M., Rappa G., D'Incalci M. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res. 1988 Apr 15;48(8):2036–2041. [PubMed] [Google Scholar]
  37. Manley J. L., Fire A., Cano A., Sharp P. A., Gefter M. L. DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. Proc Natl Acad Sci U S A. 1980 Jul;77(7):3855–3859. doi: 10.1073/pnas.77.7.3855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mariani B. D., Schimke R. T. Gene amplification in a single cell cycle in Chinese hamster ovary cells. J Biol Chem. 1984 Feb 10;259(3):1901–1910. [PubMed] [Google Scholar]
  39. McKnight S., Tjian R. Transcriptional selectivity of viral genes in mammalian cells. Cell. 1986 Sep 12;46(6):795–805. doi: 10.1016/0092-8674(86)90061-9. [DOI] [PubMed] [Google Scholar]
  40. Miller D. M., Polansky D. A., Thomas S. D., Ray R., Campbell V. W., Sanchez J., Koller C. A. Mithramycin selectively inhibits transcription of G-C containing DNA. Am J Med Sci. 1987 Nov;294(5):388–394. doi: 10.1097/00000441-198711000-00015. [DOI] [PubMed] [Google Scholar]
  41. Mitchell P. J., Carothers A. M., Han J. H., Harding J. D., Kas E., Venolia L., Chasin L. A. Multiple transcription start sites, DNase I-hypersensitive sites, and an opposite-strand exon in the 5' region of the CHO dhfr gene. Mol Cell Biol. 1986 Feb;6(2):425–440. doi: 10.1128/mcb.6.2.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ray R., Snyder R. C., Thomas S., Koller C. A., Miller D. M. Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest. 1989 Jun;83(6):2003–2007. doi: 10.1172/JCI114110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ray R., Thomas S., Miller D. M. Mithramycin selectively inhibits the transcriptional activity of a transfected human c-myc gene. Am J Med Sci. 1990 Oct;300(4):203–208. doi: 10.1097/00000441-199010000-00001. [DOI] [PubMed] [Google Scholar]
  44. Schimke R. T. Methotrexate resistance and gene amplification. Mechanisms and implications. Cancer. 1986 May 15;57(10):1912–1917. doi: 10.1002/1097-0142(19860515)57:10<1912::aid-cncr2820571004>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  45. Shimada T., Inokuchi K., Nienhuis A. W. Chromatin structure of the human dihydrofolate reductase gene promoter. Multiple protein-binding sites. J Biol Chem. 1986 Jan 25;261(3):1445–1452. [PubMed] [Google Scholar]
  46. Sive H. L., Heintz N., Roeder R. G. Multiple sequence elements are required for maximal in vitro transcription of a human histone H2B gene. Mol Cell Biol. 1986 Oct;6(10):3329–3340. doi: 10.1128/mcb.6.10.3329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Snyder R. C., Ray R., Blume S., Miller D. M. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry. 1991 Apr 30;30(17):4290–4297. doi: 10.1021/bi00231a027. [DOI] [PubMed] [Google Scholar]
  48. Srimatkandada S., Medina W. D., Cashmore A. R., Whyte W., Engel D., Moroson B. A., Franco C. T., Dube S. K., Bertino J. R. Amplification and organization of dihydrofolate reductase genes in a human leukemic cell line, K-562, resistant to methotrexate. Biochemistry. 1983 Dec 6;22(25):5774–5781. doi: 10.1021/bi00294a015. [DOI] [PubMed] [Google Scholar]
  49. Tsurusawa M., Niwa M., Katano N., Fujimoto T. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells. Cancer Res. 1988 Aug 1;48(15):4288–4293. [PubMed] [Google Scholar]
  50. Van Dyke M. W., Dervan P. B. Chromomycin, mithramycin, and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II). Biochemistry. 1983 May 10;22(10):2373–2377. doi: 10.1021/bi00279a011. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES